Division of Cullinan Oncology LLC
Latest From Cullinan Apollo
Tech Transfer Roundup: Mustang, Nationwide Children’s Hospital Collaborate In Pediatric Glioblastoma
Partnership will test Mustang’s MB-101 with a second-generation oncolytic HSV-1 virus for potential in treating brain cancer. Canadian biotech launched by CCAB to fight the same cancer.
- Therapeutic Areas
- North America
- Company Type
- Parent & Subsidiaries
- Cullinan Oncology LLC
- Senior Management
- Contact Info
One Main St.
Cambridge, MA 02142
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.